Identification of a PDGF-like mitoattractant produced by NIH/3T3 cells after transformation with SV40
- PMID: 2984217
- DOI: 10.1002/jcp.1041230203
Identification of a PDGF-like mitoattractant produced by NIH/3T3 cells after transformation with SV40
Abstract
It has previously been shown that fibroblastic cells transformed by SV40 exhibit a reduced requirement for PDGF for growth. In addition, NIH/3T3 cells lose both their chemotactic response to PDGF and specific cell surface binding of PDGF after transformation with SV40. We have now examined whether the SV40 transformed NIH/3T3 cells are producing a factor which acts similarly to PDGF. Our studies indicate that NIH/3T3 cells transformed with SV 40 produce a factor which shares many biological properties with PDGF. We were unable to detect this activity in conditioned media from nontransformed NIH/3T3 cells. The SV40/NIH/3T3 derived factor appears to possess both chemotactic and mitogenic activity for connective tissue cells but not endothelial or epithelial cells. Furthermore, in preliminary studies, this activity competes with 125I-PDGF for binding to smooth muscle cells. The biochemical properties of the SV40/NIH/3T3 derived factor are different from those of PDGF. The SV40 activity appears to reside in a heat labile acidic protein (pI less than 7.0) of MW less than 30,000 whereas PDGF is a heat stable basic protein (pI9.8) of 30,000 MW. Production of this factor may play a role in the decreased serum requirement for cell replication exhibited by SV40-transformed NIH/3T3 cells by supplying the cells with their own PDGF-like growth factor.
Similar articles
-
Differentiation-dependent production of a platelet-derived growth factor-like mitoattractant by endoderm cells derived from embryonal carcinoma cells.J Cell Physiol. 1988 Mar;134(3):437-44. doi: 10.1002/jcp.1041340315. J Cell Physiol. 1988. PMID: 2832423
-
Protamine inhibits platelet derived growth factor receptor activity but not epidermal growth factor activity.J Cell Biochem. 1984;26(4):205-20. doi: 10.1002/jcb.240260402. J Cell Biochem. 1984. PMID: 6099364
-
Differential binding, biological and biochemical actions of recombinant PDGF AA, AB, and BB molecules on connective tissue cells.J Cell Physiol. 1991 Nov;149(2):235-43. doi: 10.1002/jcp.1041490209. J Cell Physiol. 1991. PMID: 1660900
-
Platelet-derived growth factor: roles in normal and v-sis transformed cells.Cancer Surv. 1985;4(4):633-53. Cancer Surv. 1985. PMID: 2824043 Review.
-
Platelet-derived growth factors: a family of isoforms that bind to two distinct receptors.Br Med Bull. 1989 Apr;45(2):453-64. doi: 10.1093/oxfordjournals.bmb.a072334. Br Med Bull. 1989. PMID: 2557116 Review.
Cited by
-
Spontaneous expression of the c-sis gene and release of a platelet-derived growth factorlike molecule by human alveolar macrophages.J Clin Invest. 1986 Jul;78(1):61-6. doi: 10.1172/JCI112574. J Clin Invest. 1986. PMID: 3722386 Free PMC article.
-
Fibroblast chemotaxis induction by human recombinant interleukin-4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122.J Clin Invest. 1991 Jun;87(6):2147-52. doi: 10.1172/JCI115247. J Clin Invest. 1991. PMID: 2040697 Free PMC article.
-
Constitutive and inducible secretion of platelet-derived growth factor analogs by human leukemic cell lines coexpressing erythroid and megakaryocytic markers.J Clin Invest. 1987 Mar;79(3):859-66. doi: 10.1172/JCI112895. J Clin Invest. 1987. PMID: 3469217 Free PMC article.
-
Characterization of biologically active, platelet-derived growth factor-like molecules produced by murine erythroid cells in vitro and in vivo.J Clin Invest. 1990 Jan;85(1):40-6. doi: 10.1172/JCI114431. J Clin Invest. 1990. PMID: 2295703 Free PMC article.
-
The B chain of PDGF alone is sufficient for mitogenesis.EMBO J. 1985 Dec 16;4(13A):3399-405. doi: 10.1002/j.1460-2075.1985.tb04096.x. EMBO J. 1985. PMID: 3004957 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous